Figure 3

KM analysis of ECM genes with higher expression (z > 2 score) in RCC patients. (a) NUDT1, (b) SIGLEC1, (c) LRP1, (d) LOXL2, (e) SERPINE1, (f) PLOD3, (g) ZP3, (h) RARRES2, (i) TGM2, (j) COL3A1, (k) ANXA4, and (l) POSTN. The patients with higher expression (cutoff: z-score > 2) were grouped in high risk and other patients were in the low-risk group.